Speakers

Franck Amblard, PhD

Emory University

  • LinkedIn

Synthesis of Novel 2’-disubstituted Ribonucleoside Analogs

Leonid Beigelman, PhD

Aligos Therapeutics

Oligonucleotides Based Approaches for Treatment of Chronic Hepatitis B

Robert Britton, PhD

Simon Fraser University

  • LinkedIn

A de novo Nucleoside Synthesis: New Opportunities for Medicinal and Process Chemistry

Joy Feng, PhD

Gilead Sciences, Inc.

Discovery of Remdesivir and Beyond

Krishna N. Ganesh, FNA, FASc, FTWAS

Indian Institute of Science Education and Research (IISER) Tirupati

PNAs with Double Face: Bimodal PNAs as Templates for Supramolecular Assemblies of Nucleic Acids

Kenneth A. Jacobson, PhD

National Institutes of Health

  • LinkedIn

Design and Therapeutic Potential of Purinergic Receptor Ligands

Stephanie Kath-Schorr, PhD

University of Cologne

  • LinkedIn
  • Twitter

RNA Functionalization via an Expanded Genetic Alphabet

Maureen McKeague, PhD

McGill University

  • LinkedIn
  • Twitter

Ribozyme Gene Switches for Biosensing and Regeneration Studies

Ronald Micura, PhD

University of Innsbruck

A Natural Riboswitch Scaffold with Methyltransferase Activity

Prof. Barbara Nawrot

Polish Academy of Sciences

Novel DNA-boron Cluster Conjugates with Two Faces

Professor Satoshi Obika

Osaka University

  • LinkedIn

Development of Sugar-modified Oligonucleotides with Higher Enzymatic Stability Than PS Oligonucleotides

Kelvin Ogilvie, PhD

Acadia University

Therapeutic Nucleosides and Evolution of Oligonucleotide Synthesis

Bradley L. Pentelute, PhD 

MIT

  • LinkedIn

Talk Title: Coming Soon

Prof Andrea Rentmeister

University of Münster

Talk Title: Coming Soon

  • LinkedIn

Jean-Pierre Sommadossi, PhD

Atea Pharmaceuticals

Rapidly Advancing Transformational Therapeutic Solutions for Patients with Severe Viral Diseases

Olalla Vázquez, PhD

Philipps-Universität Marburg

  • Twitter

Talk Title: Coming Soon

Mark K. Schlegel, PhD

Alnylam Pharmaceuticals

  • LinkedIn

Improved Specificity of Conjugate siRNAs Through Chemical Modification

Marcus Wihelmsson, PhD

Chalmers University of Technology

  • LinkedIn

Stealth Fluorescence Labeling for Live-Cell Imaging in RNA-based Therapeutics